- Business
- Innovest Global, Inc. (IVST) is a diversified industrials company providing value-added solutions across multiple business segments including energy, construction, and services; it operates as a holding company with an acquisition-based revenue model targeting commercial, industrial, residential, and institutional customers primarily in the United States. The company reports through six segments: Energy Solutions, which offers procurement and efficiency solutions such as LED lighting retrofits for commercial and industrial clients via subsidiaries like Shepherd Energy Solutions and Primary Metering Systems; Energy Brokerage, which supplies competitive electricity and natural gas purchase programs for residential and commercial consumers through H.P. Technologies, Inc.; Call Center Services, delivering inbound and outbound customized call services on short- or long-term contracts via Contact Source Solutions, LLC; Building Solutions, which designs, engineers, tests, and assembles curtainwall systems and custom building products for large construction projects through Midwest Curtainwalls, Inc.; Wholesale Purchasing, acting as a national distributor of roofing materials, windows, fasteners, tools, and accessories via Authority National Supply; and Other, encompassing safety supplies through Chagrin Safety Supply, LLC, corporate activities, and a strategic investment in StemVax biopharmaceuticals developing therapies for brain tumors. Founded in 1999 and headquartered at 8834 Mayfield Road, Suite 150, Chesterland, Ohio, Innovest Global pursues growth through acquisitions and operational enhancements. Recent developments include leadership changes with GPC Holdings gaining voting majority control, appointment of Shaheed Bailey as Chairman and interim CEO, and Sri Vanamali as Co-Chairman and President in 2022; efforts to achieve SEC compliance for smaller reporting companies via audits by Hudgens CPA PLLC for fiscal years 2020 and 2021; distribution of 7.5 million NovaAccess shares as a dividend following the 2020 spin-out of StemVax Therapeutics; and plans for liability reduction by closing non-operating subsidiaries, strategic capital deployment, and new acquisitions to resume uplisting and expand assets.